EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS062-10633 
Organism
Homo sapiens 
Tissue/cell
GM18486 
Coordinate
chr22:18224660-18226500 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
CTCFMA0139.1chr22:18225356-18225375CAGCCACCAGAGGGCAGTG+7.65
NFYAMA0060.3chr22:18226109-18226120AACCAATCAGA+6.62
NFYBMA0502.1chr22:18226104-18226119AGACCAACCAATCAG+6.45
RREB1MA0073.1chr22:18225245-18225265CCCCACCCCCACCCCCACCC+6.27
RREB1MA0073.1chr22:18225246-18225266CCCACCCCCACCCCCACCCC+6.27
RREB1MA0073.1chr22:18225233-18225253CCTCCCCCCACCCCCCACCC+6.45
RREB1MA0073.1chr22:18225236-18225256CCCCCCACCCCCCACCCCCA+6.69
RREB1MA0073.1chr22:18225240-18225260CCACCCCCCACCCCCACCCC+7.47
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_09461chr22:18223512-18227741CD14
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr221822481218225629
chr221822568318225762
Number: 1             
IDChromosomeStartEnd
GH22I017741chr221822476118225573
Enhancer Sequence
CCAAAGTTTT CCTGATTCCC TGCAGAGCAG AGCACCCAGC TCCTCCAGCA CCTCATCACT 60
CCCCCAGCAC CGAATCTGTG CCTCGCTCGT TCCCGAAGCT TATCCACCTT GCTTCAGTTA 120
CGGACACGTC CTCTCTCCCT CTGGCCACCA GCCGAGTAGC AACAGGAATC TTTCCTGATC 180
CGTCTGTGTC CAGCCGAGTG AACGGACTCA CCAAAGAAAC CCCGGCAGCC AGAGCCTCTA 240
CCTTGCCCCT CTTTCCAGGC TCGCCAGGGA CTAGATTCAC AGTCCCTGTC ACCTGCAGGC 300
TAAGTGAACT GCCATGATCA CTTTTGCAGG TGCCACTTGA GTCAACCCCG GTTTCTCAGT 360
CTAGAGGCAA AGGCCGGCAT GGAGAAGAGC GAGAGAAAAA CACCAGGGCA GACTGGGGCT 420
ACAGTCACCC CCACAGCAGT GCTGACAGCA GAGCTGTGCC TGTCCACTCC TGCCCTTCCT 480
GGACCTTCCC AAAGGGATCT GGGGTTTCTC CTCAGTTCAG GGCGAGCCAG AAGATATGCT 540
GGCTGGATTA GAAGGCAGAG ACATTCTCAG ACACCTCCCC CCACCCCCCA CCCCCACCCC 600
CACCCCGGTC TAGTGGGGAA CTCCAGCCAC GTCCTCAAGC ACCTGATCTA AGACAGGCGG 660
GAGGCAGAAG GCTGGGTCAG CTGTTGGTCT CCCCCACAGC CACCAGAGGG CAGTGCAACC 720
CTTGAGCTTG GAAGGCCTGG ACCAGGGTCC GGGGATCCCT GCAGGCTTTC AGGGCAGGGA 780
TTCTACCTGC GTCAGAATCC TCTGGGCAGT CTCCCGCCCT AAAACAGCCT GATGCAGGCA 840
GCTGGAGTAG GGCCCAAGGC CTGCATTTGG AAAAGGTTTC TCGTGTAATT CCAATGTGCA 900
CACTACTGAA AGCCAGCGTC GCAGGGCTGG ATCTGGAAGT GGGTGAGCCT CCACTCGCCC 960
CCAGCCTCCA CTCGGGACAG CCCCTGTCCA TAGAAGCAGC CCCTTGGCAA AGGGGAGTGG 1020
AGCTGGAGGC TGGAGGAGAG TGCAGGGATC AGCAACAGGA AAGGTGAACA GTCTGGAAAC 1080
CATGGTGACC TGGAGTCAGT GCCCTACAGT GGGAGGGCGG CTGAGGCCCA CCTCAAGAAG 1140
GGGCCTGGCC CCATGTCCCA GTGGTAACAT GGCCACAAGC TGTGTGATCT GGAGCTAGTC 1200
ATTTACCCTT TGCTGGACCT GGGTTTCCTC ACCTGGAAAT GAGGTTCCAA ATACTTCTGT 1260
GTTCTTGTAT AGGTAATCAC GGAGCATAAT GTATGAAAGG AAATATGTCA GGTATAGACA 1320
GTGCAAAAGT CACTGTGAAA CCAGTGGGCC TCAATCAATG GGACAGTCAG CCAGGCCTGC 1380
TTGGGGAGGC AGGGGCCGCA CCGGTAGTGC CACCTGGGGG CTTTGCCCAG ACCCAGCAAT 1440
GCCCAGACCA ACCAATCAGA ATCTCTGGAG GTGAGATGCA GGCACCAGCA TTTAAAGCTC 1500
CAGGTCCTTG AAATGATACA AGGCCAAGTG TGAGAACCCC TTGGGTTATA TAATCCAGAC 1560
AAGTGGTCTG CAATCTTTGT ATCAGAATCA CATTTGGAAA ATTGGATAAA AACACCATTC 1620
TATGTTGGTC CAGACAAGGG ACTCAAGACC AGTACATGAG ATTCTGTCTC AACAGAAAGG 1680
AAGAACTTTC TAACAGAGTC ACCCAAAAAT GGTAGGCAGT GAGTTCAGCA GCACTGGAGG 1740
GAATCAAGTA GAGACCAGTC AAGTGATTAA GTGATACCAG CGTACGTGGC AGCTGAAACT 1800
GCAGAGGCAG AGTGATCCCG GGGGTCCCTT CCAGCCCTGA 1840